Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

WHO recommends reduced dose Pfizer COVID vaccine for under 12s

Stock MarketsJan 21, 2022 11:37AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
2/2 © Reuters. FILE PHOTO: Doses of the Pfizer-BioNTech vaccine against the coronavirus disease (COVID-19) for children are prepared at a children doctor's practice in Maintal near Frankfurt, Germany, December 15, 2021. REUTERS/Kai Pfaffenbach 2/2

By Mrinalika Roy and Manojna Maddipatla

(Reuters) -The World Health Organization on Friday recommended extending the use of a reduced dosage of Pfizer (NYSE:PFE)'s COVID-19 vaccine to children aged 5 to 11 years old.

The recommendation comes after the Strategic Advisory Group of Experts (SAGE) on immunisation held a meeting on Wednesday to evaluate the vaccine. It is currently recommended for use in people aged 12 years and above.

The recommended dosage for the younger population is 10 micrograms instead of 30 micrograms offered to those 12 years and older.

"This age group (5-11) is in the lowest priority use group for vaccination except, for children who have co-morbidities," SAGE chairman Alejandro Cravioto said at a briefing.

Pfizer/BioNTech shots have already been authorised for use in the age group in several countries including the United States, Canada, Israel, and the European Union.

The WHO's vaccine director, Kate O'Brien, said no safety concerns were raised for application of Pfizer's vaccine in 5 to 11 years old in clinical trials.

The panel also recommended that booster doses of Pfizer's vaccine should be administered 4 months to 6 months after the completion of the primary series, in high-priority groups like older adults and health workers.

Countries with moderate to high vaccination rates should prioritise available vaccine supply to first achieve high booster dose coverage in higher risk groups before offering vaccine doses to lower risk groups.

"Increase in booster dose coverage for high risk priority groups will usually yield greater reduction in severe disease and deaths than use of equivalent vaccine to increase primary vaccination coverage," Cravioto added.

Cravioto said the revised roadmap for prioritisation for COVID vaccines took into account the increasing availability of vaccines, current coverage and the circulation of variants of concern.

The panel said the recommendation for use of Pfizer's booster dose was only for certain priority groups and that it was not endorsing "unfettered" use in all ages.

"We simply don't have evidence yet on the need for or the evidence on the performance of boosters (in children below 12 years of age)," O'Brien said.

WHO recommends reduced dose Pfizer COVID vaccine for under 12s
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (1)
Raja Tampan
Raja Tampan Jan 21, 2022 10:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
But too late, it has already many children become the victim of the vaccines in Southeast Asia countries. Will you be the responsible?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email